SVP, Strategy and Business Development

Director, IRT and Technology Lead

Alexion Pharmaceuticals discloses C1S inhibitors

AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com

AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results

Axial AI Governance Director

Alexion Pharmaceuticals, Inc. is seeking an Axial AI Governance Director to shape responsible AI practices across the enterprise. The role involves designing and implementing AI governance frameworks, collaborating with various departments to ensure compliance, and leading initiatives that promote safe experimentation and innovation.

Executive Director and Chief Executive Officer

Group CFO and Executive Director

Unicorn Factory Lisboa – scaling to international horizons

AbelZeta Sells Remaining China Rights To GPC3 Armored CAR-T Program To AstraZeneca

GSK licenses Alteogen enzyme in bid to develop subQ Jemperli

Microfluidic Devices Market Size to Reach USD 17.09 Billion by 2033, Driven by Rapid Diagnostics and Lab-on-a-Chip Adoption – SNS Insider

AstraZeneca is a mission-led, fast-growing organization focused on leveraging AI to accelerate scientific progress and deliver medicines to patients worldwide. The Axial AI Governance Director will lead the design and implementation of an AI Governance Framework, ensuring safe, compliant adoption of AI while balancing innovation with risk management.

Axial Ai Governance Director

Axial Ai Governance Director in united states (1000+)

Axial AI Governance Director

Axial AI Governance Director